MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2026 International Congress

October 4-8, 2026. Seoul, Korea.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • In Vivo 18F-Florzolotau Tau PET Imaging in Parkinson’s Disease with and without Probable REM Sleep Behavior Disorder

    C. Xu, Y. Tang, J. Wang (Shanghai, China)

  • Incidence and movement disorders associated with Steroid-Responsive Encephalopathy Associated with Autoimmune Thyroiditis (SREAT) in the Princess Maha Chakri Sirindhorn Medical Center (MSMC)

    K. Methawasin, N. Suthumchai, N. Wangwiwatcharoen, K. Anuroj (Nakhon Nayok, Thailand)

  • Incidence and Outcomes of Hip Fractures in Parkinsonism vs Non-Parkinson Population: A Systematic Review of the Literature

    U. Saini (Chandigarh, India)

  • Incisionless versus Implantable: A Comparative Systematic Review of Magnetic Resonance-Guided Focused Ultrasound (MRgFUS) Thalamotomy versus Deep Brain Stimulation in Tremor-Dominant Parkinson’s Disease: Long-Term Durability and Safety Outcomes

    A. Al-Zaidi, F. Al-Zaidi, Z. Hussein (Salahddin, Iraq)

  • IncobotulinumtoxinA for the Treatment of Lower Limb Spasticity in Children and Adolescents with Cerebral Palsy Evaluation of Lower Limb IncobotulinumtoxinA Efficacy (ELLIE)

    I. Makedonska (Dnipro, Ukraine)

  • IncobotulinumtoxinA to Treat Sialorrhea in Parkinson’s Disease: a Real-life Study: 7-year Interim Results

    B. Bergmans, N. Winter, V. Schotte, N. Sys, E. van Massenhove, G. Pollet, M. van Zandijcke (Bruges, Belgium)

  • Increased Pre-Alpha EEG Functional Connectivity Forecasts Future Cognitive Decline in Parkinson’s Disease

    A. Tetereva, G. Hall-Mcmaster, N. Slater, A. Harris, R. Shoorangiz, C. Le Heron, R. Keenan, I. Kirk, W. Meissner, T. Anderson, T. Melzer, N. Pat, J. Dalrymple-Alford (Christchurch, New Zealand)

  • Influence of Disease Duration on Motor Progression in Parkinson’s Disease: A Longitudinal Cohort Study with Age at Onset Stratification and Sensitivity Analysis

    N. Babu, S. Prasad, T. Nagaraj, S. Bhat, M. Bhardwaj, SS. Aramugham, K. Kumar, R. Mahale, P. Mailankody, V. Holla, N. Kamble, R. Yadav, P. Pal (Bengaluru, India)

  • Influence of disease stage upon real-world turning performance in people with Parkinson’s

    C. Wilkinson, S. Del Din, C. Schlenstedt, C. Becker, J. Buekers, B. Caulfield, L. Delgado, J. Garcia-Aymerich, H. Gassner, A. Nieuwboer, J. Hausdorff, A. Mirelman, L. Rochester, W. Maetzler, A. Yarnall, L. Alcock (Newcastle-upon-Tyne, United Kingdom)

  • Inpatient Titration Protocol and Practical Implementation of Continuous Subcutaneous Foslevodopa/Foscarbidopa: Lessons from 28 Consecutive Cases

    Y. Abdelmajid, M. Thomas, K. Waqar, E. de Freitas, R. Cabrito, R. Battah, A. Anjum, S. Mittal (Abu Dhabi, United Arab Emirates)

  • « Previous Page
  • 1
  • …
  • 103
  • 104
  • 105
  • 106
  • 107
  • …
  • 208
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley